1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPandemic Antiviral Discovery (PAD) is sponsored by Bill & Melinda Gates Foundation, Novo Nordisk Foundation, Open Philanthropy. A global philanthropic initiative to catalyze discovery and early development of antiviral drug candidates for future pandemics.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
PAD – Antivirals for Pandemic Influenza – Request For Proposals 2022/2023 14 December 2022 2:00pm (Copenhagen time) Phase 1 results expected by the end of May 2023 Rules, grant administration and FAQ Up to USD 10 million per grant Grant Manager, Grant Management Pandemic Antiviral Discovery (PAD) is a global philanthropic initiative launched by the Bill & Melinda Gates Foundation and Open Philanthropy in the US, and the Novo Nordisk Foundation (NNF) in Denmark.
The aspiration of PAD is to catalyze the discovery and early development of antiviral medicines in preparation for future outbreaks of infectious diseases with pandemic potential. With equitable access as a core principle of the initiative, the founding partners are committed to ensuring that discoveries and innovations supported by PAD are accessible for people in low- and middle-income countries.
By focusing on small molecules for oral delivery, these efforts can help ensure the world is prepared to quickly develop and deploy effective, accessible antiviral drugs next time the world faces a pandemic threat.
Frequently asked questions about the PAD initiative: Frequently Asked Questions: PAD Initiative – Pandemic Antiviral Discovery If the eligibility criteria listed below are not adhered to in the submitted proposal, it will receive an administrative rejection PAD seeks to actively engage researchers from all over the world as part of the drug discovery process, but applicants must be established investigators with their own line of research and must be employed for the duration of the project at the administrating institution registered in the proposal.
The administrating institution/organization must be able to accept and manage the potential grant. Projects can be anchored at any type of research organization, including academia, not-for profit and commercial organizations. The scope of the project must be within the scientific scope of this RfP and support the PAD aspirations.
An applicant (i.e., the principal investigator (PI) responsible for the project and submitting the proposal) may submit only one proposal to this specific RfP. Different PI’s can be anchored at the same institution/organization.
Co-applicants can be a part of more than one proposal to this RfP, and an applicant on one proposal can be a co-applicant or collaborator on other proposals A total of up to USD 25 million is expected to be allocated to proposals submitted to this RfP, but this amount is not fixed and may be updated depending on the quantity and quality of the proposals. The number of proposals supported will depend on the quality and expected budget.
Exploratory projects should not exceed a budget of approximately USD 2 million and later-stage validation projects should not exceed a budget of approximately USD 10 million. It is expected that the projects applied for will be between 1 and 3 years in duration. The application and evaluation process consists of two phases.
The entire process from first proposal to potential grant is outlined in the ‘Information and guidelines for applicants – PAD – Antivirals for Pandemic Influenza – Request for proposals 2022/2023. ’ Please read these guidelines carefully before initiating the application process.
The application must be completed in English and submitted using the Novo Nordisk Foundation’s online application and grant management system, NORMA, which can be accessed by clicking on the ‘Apply’ button. All the projects we have funded are listed here. You can customise your search by grant year and category and use free text search.
NNF Kenya A/S Branch Office NNF India A/S Branch Office Etiske regler for større byggeprojekter Tilmeld dig for sidste nyt Ja tak, jeg vil gerne modtage relevante nyhedsbreve fra Novo Nordisk Fonden med nyheder. Indsæt venligst en korrekt email
According to the current listing, eligibility includes: Researchers worldwide, including academic institutions and private sector funders, with an emphasis on equitable access to discoveries for low- and middle-income countries. Confirm the full requirements in the official notice before applying.
Pandemic Antiviral Discovery (PAD) is funded by Bill & Melinda Gates Foundation, Novo Nordisk Foundation, Open Philanthropy. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
MacKenzie Scott's Yield Giving has moved more than $26 billion — including roughly $7 billion in 2025, over a third of all U.S. megagifts — through unrestricted, trust-based grants with no application. Melinda French Gates's Pivotal Ventures has committed $2 billion to women's health and economic power. The Bezos philanthropies have moved billions more. As the Buffett–Gates era winds down, this new class of megadonor is rewriting the rules of major giving. Here is what changes for nonprofits, and how to become the kind of organization this money finds.
Read articleThe Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleGates committed $540.2 million over a decade to the Institute for Health Metrics and Evaluation — the largest gift in University of Washington history — while IHME's federal grant income falls from $7.3 million to a projected $4.8 million. The gift is a case study in the anchor-funder model: what it can do that federal money cannot, and the concentration risk it quietly underwrites.
Read article